Injective price surges as Nasdaq lists Canary staked INJ ETF

The price of Injective has seen a sharp increase of over 10 percent today, reacting to a major development in the institutional product space. Nasdaq has officially approved the listing of an exchange traded fund managed by Canary that focuses specifically on staked INJ. This marks one of the first times that a staked asset has been integrated into a tradable product on a major national stock exchange.

Investors are responding positively to the news because it provides a bridge between the high yield potential of staking and the liquidity of traditional brokerage accounts. By holding the ETF, investors can gain exposure to the token price while simultaneously benefiting from the staking rewards accrued by the underlying assets. This structure is highly attractive to institutional players who want to earn yield without managing the technical complexities of hardware wallets or validator nodes.

Market data shows that the trading volume for the asset has spiked significantly since the announcement. The move suggests a growing appetite for specialized financial products that go beyond simple spot tracking. Analysts believe that this approval could set a precedent for other yield bearing tokens to receive similar treatment, provided they meet the stringent compliance standards required by exchange operators and regulators.

Beyond the price action, the development is a victory for the Injective ecosystem. The increased attention from institutional investors usually translates to higher liquidity and more stable long term support for the network. As more capital flows into the ETF, the total amount of tokens locked in staking contracts is expected to increase, which could further reduce the circulating supply and create additional price pressure.

Traders are now watching closely to see if this momentum holds through the weekend. While the 10 percent gain is a strong signal of market confidence, volatility is expected as the ETF begins trading and initial arbitrage opportunities are settled. For now, the narrative surrounding the INJ token has shifted from speculative trading to a broader recognition of its utility in the growing sector of programmable finance.